All Curated Mutation Sites in HCV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HCV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
5'UTR
  
C
  
E1
  
E2
  
NS2
  
NS3
  
NS4B
  
NS5A
  
NS5B
  
p7
  
Protease
  

Keyword: Cell line-35763545
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 35763545 I1834L
NS4B
NS4B
Cell line
G
View
2 35763545 K1846T
NS4B
NS4B
Cell line
G
View
3 35763545 S1827T
NS4B
NS4B
Cell line
G
View
4 35763545 R1649K
NS4A
NS4A
Cell line
G
View
5 35763545 A1226G
NS3
NS3
Cell line
G
View
6 35763545 K1052R
NS3
NS3
Cell line
G
View
7 35763545 V1074I
NS3
NS3
Cell line
G
View
8 35763545 I888V
NS2
NS2
Cell line
G
View
9 35763545 V899A
NS2
NS2
Cell line
G
View
10 35763545 F437L
E2
E2
Cell line
G
View
11 35763545 H202Y
E2
E2
Cell line
G
View
12 35763545 Q434R
E2
E2
Cell line
G
View
13 35763545 V719L
E2
E2
Cell line
G
View
14 35763545 I30T
C
Core
Cell line
G
View
15 35763545 N2415S Cell line
G
View
16 35763545 C2864F
NS5B
NS5B
Cell line
G
View
17 35763545 N2561T
NS5B
NS5B
Cell line
G
View
18 35763545 Q2603K
NS5B
NS5B
Cell line
G
View
19 35763545 N2152S
NS5A
NS5A
Cell line
G
View
20 35763545 R2080K
NS5A
NS5A
Cell line
G
View
21 35763545 S2341P
NS5A
NS5A
Cell line
G
View
22 35763545 V2340A
NS5A
NS5A
Cell line
G
View
23 35763545 Y2385H
NS5A
NS5A
Cell line
G
View
Contents
Description

The table shows all curated mutation sites of HCV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.